ArticleDEN open2026
A Case of Pancreatic Neuroendocrine Tumor Growing Intraductal Extension toward the Main Pancreatic Duct Complicated by Thrombocytopenia: Diagnostic Challenges and Management Strategy.
Article in DEN open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- A Rare Case of Pancreatic Neuroendocrine Tumor with Intraductal Extension in the Dorsal Duct of a Pancreas Divisum.Reports (MDPI) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a rare and diagnostically challenging case of a pancreatic neuroendocrine tumor (pNET) with intraductal growth into the main pancreatic duct (MPD), complicated by severe thrombocytopenia due to myelodysplastic syndrome. A 37-year-old male presented with thrombocytopenia. Abdominal imaging revealed an 11-mm hypervascular lesion obstructing the MPD in the pancreatic body. The initial serial pancreatic juice aspiration cytological examination (SPACE) demonstrated Class II cytology. Eight months later, the second SPACE revealed Class V cytology. Pancreaticoduodenectomy confirmed pNET G2 with clear intraductal extension. In the postoperative specimen, a portion of the tumor was exposed within the MPD, suggesting Class V cytology. pNETs with intraductal extension (I-pNETs) are rare, as pNETs typically exhibit expansive encapsulated growth. SPACE may be a valuable diagnostic alternative for patients with thrombocytopenia, although its accuracy may depend on factors such as capsular integrity and ductal communication. Tailored diagnostic strategies that balance invasiveness and safety are essential for managing pancreatic tumors in patients with hematological fragility. This case highlights the importance of considering I-pNET in the differential diagnosis of MPD-occupying lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.